Background Mavacamten, a selective cardiac myosin inhibitor, is a therapeutic option for hypertrophic cardiomyopathy (HCM). Its impact on exercise capacity, health-related quality of life and left ...
EUGENE, Ore. – Ole Miss men's and women's track & field will be represented by 10 student-athletes in six different events on ...